Cagrilintide One phase 2 trial demonstrated that weekly injections of cagrilintide induced 10.8% weight loss over 26 weeks, compared to 9% with liraglutide, and 3% with placebo (mean age 52.3 years, with no upper age limit)
First, there is uncertainty regarding whether a short-term reduction in weight and improvement in other cardiovascular risk factors, depending on the duration of treatment, will lead to a decrease in the occurrence of complications and mortality in individuals who have been obese for an extended period of time
GLP-1RAs ameliorate ROS-induced or hyperglycemia-induced apoptosis through modulating IL-6 production and ER stress-induced by hyperhomocysteinemia, via stromal cell-derived factor (SDF)-1/C-X-C motif receptor 7 (CXCR7) -AMPK/p38-MAPK axis [113-115]
Thus, the idea of utilising glucagon RAs for metabolic disease would seem counterintuitive, at least in people with diabetes
Curriculum Highlights The AAOPM weight loss certification program addresses the core competencies required to deliver clinical weight management at the highest standard
Despite this critical aspect, more nanoparticle-based therapeutics is expected to become available in the near future, with the goal to fulfill official guidelines approved by the international scientific and medical community (Hare et al., 2017